170 related articles for article (PubMed ID: 31327041)
41. Perfusion CT measurements predict tumor response in rectal carcinoma.
Kino A; Shaffer J; Maturen KE; Schmiedeskamp H; Koong AC; Chang DT; Fleischmann D; Kamaya A
Abdom Radiol (NY); 2017 Apr; 42(4):1132-1140. PubMed ID: 28008455
[TBL] [Abstract][Full Text] [Related]
42. The role of diffusion-weighted MRI and (18)F-FDG PET/CT in the prediction of pathologic complete response after radiochemotherapy for rectal cancer: a systematic review.
Joye I; Deroose CM; Vandecaveye V; Haustermans K
Radiother Oncol; 2014 Nov; 113(2):158-65. PubMed ID: 25483833
[TBL] [Abstract][Full Text] [Related]
43. Neither FDG-PET Nor CT can distinguish between a pathological complete response and an incomplete response after neoadjuvant chemoradiation in locally advanced rectal cancer: a prospective study.
Guillem JG; Ruby JA; Leibold T; Akhurst TJ; Yeung HW; Gollub MJ; Ginsberg MS; Shia J; Suriawinata AA; Riedel ER; Mazumdar M; Saltz LB; Minsky BD; Nash GM; Paty PB; Temple LK; Weiser MR; Larson SM
Ann Surg; 2013 Aug; 258(2):289-95. PubMed ID: 23187748
[TBL] [Abstract][Full Text] [Related]
44. Early prediction of response by ¹⁸F-FDG PET/CT during preoperative therapy in locally advanced rectal cancer: a systematic review.
Maffione AM; Chondrogiannis S; Capirci C; Galeotti F; Fornasiero A; Crepaldi G; Grassetto G; Rampin L; Marzola MC; Rubello D
Eur J Surg Oncol; 2014 Oct; 40(10):1186-94. PubMed ID: 25060221
[TBL] [Abstract][Full Text] [Related]
45. Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: correlation with endorectal ultrasound and histopathology.
Amthauer H; Denecke T; Rau B; Hildebrandt B; Hünerbein M; Ruf J; Schneider U; Gutberlet M; Schlag PM; Felix R; Wust P
Eur J Nucl Med Mol Imaging; 2004 Jun; 31(6):811-9. PubMed ID: 14762698
[TBL] [Abstract][Full Text] [Related]
46. Developing a prediction model based on MRI for pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Wan L; Zhang C; Zhao Q; Meng Y; Zou S; Yang Y; Liu Y; Jiang J; Ye F; Ouyang H; Zhao X; Zhang H
Abdom Radiol (NY); 2019 Sep; 44(9):2978-2987. PubMed ID: 31327039
[TBL] [Abstract][Full Text] [Related]
47. Prediction of tumor response after neoadjuvant chemoradiotherapy in rectal cancer using (18)fluorine-2-deoxy-D-glucose positron emission tomography-computed tomography and serum carcinoembryonic antigen: a prospective study.
Li QW; Zheng RL; Ling YH; Wang QX; Xiao WW; Zeng ZF; Fan W; Li LR; Gao YH
Abdom Radiol (NY); 2016 Aug; 41(8):1448-55. PubMed ID: 27116012
[TBL] [Abstract][Full Text] [Related]
48. Restaging of locally advanced carcinoma of the rectum with MR imaging after preoperative radio-chemotherapy plus regional hyperthermia.
Hoffmann KT; Rau B; Wust P; Stroszczynski C; Hünerbein M; Schneider U; Felix R
Strahlenther Onkol; 2002 Jul; 178(7):386-92. PubMed ID: 12163993
[TBL] [Abstract][Full Text] [Related]
49. Positron emission tomography for predicting pathologic response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
Chennupati SK; Quon A; Kamaya A; Pai RK; La T; Krakow TE; Graves E; Koong AC; Chang DT
Am J Clin Oncol; 2012 Aug; 35(4):334-9. PubMed ID: 21422989
[TBL] [Abstract][Full Text] [Related]
50. (18)F-Fluorodeoxyglucose positron emission tomography ((18)F-FDG PET) for the early detection of response to neoadjuvant chemotherapy for locally advanced rectal cancer.
Nishimura J; Hasegawa J; Ogawa Y; Miwa H; Uemura M; Haraguchi N; Hata T; Yamamoto H; Takemasa I; Mizushima T; Nezu R; Doki Y; Mori M
Surg Today; 2016 Oct; 46(10):1152-8. PubMed ID: 26711129
[TBL] [Abstract][Full Text] [Related]
51. Diagnostic performance of magnetic resonance to assess treatment response after neoadjuvant therapy in patients with locally advanced rectal cancer.
Nahas SC; Nahas CSR; Cama GM; de Azambuja RL; Horvat N; Marques CFS; Menezes MR; Junior UR; Cecconello I
Abdom Radiol (NY); 2019 Nov; 44(11):3632-3640. PubMed ID: 30663025
[TBL] [Abstract][Full Text] [Related]
52. The value of diffusion kurtosis magnetic resonance imaging for assessing treatment response of neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Yu J; Xu Q; Song JC; Li Y; Dai X; Huang DY; Zhang L; Li Y; Shi HB
Eur Radiol; 2017 May; 27(5):1848-1857. PubMed ID: 27631106
[TBL] [Abstract][Full Text] [Related]
53. Combined T2w volumetry, DW-MRI and DCE-MRI for response assessment after neo-adjuvant chemoradiation in locally advanced rectal cancer.
Intven M; Monninkhof EM; Reerink O; Philippens ME
Acta Oncol; 2015 Nov; 54(10):1729-36. PubMed ID: 25914930
[TBL] [Abstract][Full Text] [Related]
54. Delineation of gross tumor volume (GTV) for radiation treatment planning of locally advanced rectal cancer using information from MRI or FDG-PET/CT: a prospective study.
Brændengen M; Hansson K; Radu C; Siegbahn A; Jacobsson H; Glimelius B
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e439-45. PubMed ID: 21641122
[TBL] [Abstract][Full Text] [Related]
55. Performance of diffusion-weighted magnetic resonance imaging at 3.0T for early assessment of tumor response in locally advanced rectal cancer treated with preoperative chemoradiation therapy.
Delli Pizzi A; Cianci R; Genovesi D; Esposito G; Timpani M; Tavoletta A; Pulsone P; Basilico R; Gabrielli D; Rosa C; Caravatta L; Di Tommaso M; Caulo M; Filippone A
Abdom Radiol (NY); 2018 Sep; 43(9):2221-2230. PubMed ID: 29332248
[TBL] [Abstract][Full Text] [Related]
56. Utility of MRI and PET/CT after neoadjuvant chemotherapy in breast cancer patients: correlation with pathological response grading system based on tumor cellularity.
Kim T; Kang DK; An YS; Yim H; Jung YS; Kim KS; Kang SY; Kim TH
Acta Radiol; 2014 May; 55(4):399-408. PubMed ID: 23963151
[TBL] [Abstract][Full Text] [Related]
57. Predictive value of 18F-FDG PET/CT on survival in locally advanced rectal cancer after neoadjuvant chemoradiation.
Niccoli Asabella A; Simone M; Ballini A; Altini C; Ferrari C; Lavelli V; De Luca R; Inchingolo F; Rubini G
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8227-8236. PubMed ID: 30556862
[TBL] [Abstract][Full Text] [Related]
58. What Is the Ideal Tumor Regression Grading System in Rectal Cancer Patients after Preoperative Chemoradiotherapy?
Kim SH; Chang HJ; Kim DY; Park JW; Baek JY; Kim SY; Park SC; Oh JH; Yu A; Nam BH
Cancer Res Treat; 2016 Jul; 48(3):998-1009. PubMed ID: 26511803
[TBL] [Abstract][Full Text] [Related]
59. Correlation between quantitative and semiquantitative parameters in DCE-MRI with a blood pool agent in rectal cancer: can semiquantitative parameters be used as a surrogate for quantitative parameters?
Dijkhoff RAP; Maas M; Martens MH; Papanikolaou N; Lambregts DMJ; Beets GL; Beets-Tan RGH
Abdom Radiol (NY); 2017 May; 42(5):1342-1349. PubMed ID: 28050622
[TBL] [Abstract][Full Text] [Related]
60. [Preoperative diagnostic procedures in locally advanced rectal carcinoma (> or =T3 or N+). What does endoluminal ultrasound achieve at staging and restaging (after neoadjuvant radiochemotherapy) in contrast to computed tomography?].
Liersch T; Langer C; Jakob C; Müller D; Ghadimi BM; Siemer A; Markus PM; Füzesi L; Becker H
Chirurg; 2003 Mar; 74(3):224-34. PubMed ID: 12647079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
